Extrahepatic cholestasis associated with paracoccidioidomycosis: Challenges in the differential diagnosis of biliopancreatic neoplasia

Table 1 Clinical manifestations of patients with paracoccidioidomycosis and extrahepatic cholestasis allocated to the clinical management (group 1) and clinical/endoscopic/surgical management (group 2) groups, n (%)

Symptom	Group 1 (n = 27)	Group 2 (n = 13)	P value
Abdominal pain	26 (96.2)	10 (76.9)	0.092
Lymphadenomegaly	25 (92.5)	9 (69.2)	0.074
Hepatomegaly	21 (77.7)	7 (53.8)	0.153
Skin lesions	21 (77.7)	12 (92.3)	0.393
Choluria	18 (66.6)	7 (53.8)	0.498
Splenomegaly	18 (66.6)	7 (53.8)	0.498
Fever	17 (62.9)	7 (53.8)	0.733
Vomiting	12 (44.4)	5 (38.5)	1.000
Weight loss (> 10 kg)	8 (29.6)	8 (61.5)	0.085
Ascites	7 (25.9)	3 (23.0)	1.000
Pruritus	6 (22.2)	8 (61.5)	0.031